Late-onset hemophagocytic lymphohistiocytosis associated with monoallelic STX11 mutation in an adult: a case report and rationale for early allogeneic hematopoietic cell transplantation.

IF 2.4 3区 医学 Q2 HEMATOLOGY
Jan Mateusz Zaucha, Andrzej Mital, Michał Taszner, Agata Ogłoza, Jan Maciej Zaucha, Rafał Machowicz
{"title":"Late-onset hemophagocytic lymphohistiocytosis associated with monoallelic STX11 mutation in an adult: a case report and rationale for early allogeneic hematopoietic cell transplantation.","authors":"Jan Mateusz Zaucha, Andrzej Mital, Michał Taszner, Agata Ogłoza, Jan Maciej Zaucha, Rafał Machowicz","doi":"10.1007/s00277-025-06599-1","DOIUrl":null,"url":null,"abstract":"<p><p>Late-onset familial hemophagocytic lymphohistiocytosis (fHLH) remains a diagnostic and therapeutic challenge, particularly in adult patients presenting without a clear family history. We report a fatal case of HLH in a previously healthy adult harboring a monoallelic STX11 mutation. The patient presented with progressive jaundice, persistent high-grade fever, and pancytopenia, and was unresponsive to HLH-2004 protocol therapy with etoposide and dexamethasone, as well as subsequent salvage regimens. Despite aggressive treatment, the disease remained refractory, ultimately resulting in multi-organ failure. This case, alongside a review of reported adult-onset fHLH cases, highlights the diagnostic value of early genetic testing in adults with unexplained HLH, especially after secondary causes have been ruled out. Our findings underscore the importance of timely consideration of underlying genetic predisposition, even in the absence of biallelic mutations or childhood onset. Given the poor response to conventional therapies, early referral for allogeneic hematopoietic cell transplantation should be prioritized in suspected or confirmed fHLH cases to improve survival outcomes.</p>","PeriodicalId":8068,"journal":{"name":"Annals of Hematology","volume":" ","pages":""},"PeriodicalIF":2.4000,"publicationDate":"2025-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of Hematology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00277-025-06599-1","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Late-onset familial hemophagocytic lymphohistiocytosis (fHLH) remains a diagnostic and therapeutic challenge, particularly in adult patients presenting without a clear family history. We report a fatal case of HLH in a previously healthy adult harboring a monoallelic STX11 mutation. The patient presented with progressive jaundice, persistent high-grade fever, and pancytopenia, and was unresponsive to HLH-2004 protocol therapy with etoposide and dexamethasone, as well as subsequent salvage regimens. Despite aggressive treatment, the disease remained refractory, ultimately resulting in multi-organ failure. This case, alongside a review of reported adult-onset fHLH cases, highlights the diagnostic value of early genetic testing in adults with unexplained HLH, especially after secondary causes have been ruled out. Our findings underscore the importance of timely consideration of underlying genetic predisposition, even in the absence of biallelic mutations or childhood onset. Given the poor response to conventional therapies, early referral for allogeneic hematopoietic cell transplantation should be prioritized in suspected or confirmed fHLH cases to improve survival outcomes.

成人中与单等位基因STX11突变相关的晚发性噬血细胞淋巴组织细胞病:一例报告和早期异基因造血细胞移植的基本原理
迟发性家族性噬血细胞淋巴组织细胞病(fHLH)仍然是诊断和治疗的挑战,特别是在没有明确家族史的成年患者中。我们报告了一个致命的病例HLH在以前健康的成年人携带单等位基因STX11突变。患者表现为进行性黄疸,持续高热和全细胞减少,对依托泊苷和地塞米松的HLH-2004方案治疗以及随后的挽救方案无反应。尽管进行了积极的治疗,该病仍然难治性,最终导致多器官衰竭。本病例,连同对已报告的成人发病的fHLH病例的回顾,强调了早期基因检测对不明原因的成人HLH的诊断价值,特别是在排除了继发原因后。我们的研究结果强调了及时考虑潜在遗传易感性的重要性,即使在没有双等位基因突变或儿童发病的情况下。鉴于对常规治疗的不良反应,对于疑似或确诊的fHLH病例,应优先考虑早期转诊异体造血细胞移植,以改善生存结果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Annals of Hematology
Annals of Hematology 医学-血液学
CiteScore
5.60
自引率
2.90%
发文量
304
审稿时长
2 months
期刊介绍: Annals of Hematology covers the whole spectrum of clinical and experimental hematology, hemostaseology, blood transfusion, and related aspects of medical oncology, including diagnosis and treatment of leukemias, lymphatic neoplasias and solid tumors, and transplantation of hematopoietic stem cells. Coverage includes general aspects of oncology, molecular biology and immunology as pertinent to problems of human blood disease. The journal is associated with the German Society for Hematology and Medical Oncology, and the Austrian Society for Hematology and Oncology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信